Morgan Stanley: 12 new product launches will pave the way for Ambu
Ambu's many product launches provide beneficial opportunities for Ambu, according to analyst group at investment banking company Morgan Stanley.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Morgan Stanley analysts support the financial institution's positive coverage of Ambu, which was initiated with the recommendation "overweight" and a DKK 350 (USD 56.4) price target.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu expands US contracts with single-use endoscopes
For subscribers
